Microsoft Word - 150202_PDL-1_final_en - PD-1 - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-02-03 02:46:54 Non-small-cell lung carcinoma Immunotherapy Cancer PD-1 Targeted therapy Metastasis Carcinogenesis Bevacizumab Galena Biopharma Medicine Lung cancer Cancer treatments		Microsoft Word - 150202_PDL-1_final_en Add to Reading List Source URL: www.roche.com Download Document from Source Website File Size: 105,12 KB Share Document on Facebook

	Research A population-based analysis of patients with early-stage HER2-positive breast cancer DocID: 1aqN0 - View Document
	(Significantly Regulated) Listing of U.S. Industries for Filing Year 2014 Company Galectin Therapeutics Inc. Galena Biopharma, Inc. Gelstat Corporation Geltech Solutions, Inc. DocID: Zi3X - View Document
	Microsoft Word - FSI Press Release_Final-19Jan15 DocID: Z8U2 - View Document
	Early breast cancer Initial PBS authority application and supporting information Purpose of this form DocID: VzNP - View Document
	Draft protocol to guide the assessment of HER2 testing in advanced gastric cancer DocID: SVaO - View Document